Elevations in NDEV total tau, NRGN and REST levels with advancing AD severity and their associations with cognitive and functional decline might reflect the aggravation of neuronal and synaptic damage during the course of AD dementia. This evidence concerns the gene MAPT and Alzheimer disease.